Can the Written Word Fuel Pharmaceutical Innovation? Part 1. An
Emerging Vista from von Economo to COVID-19

Gerald   H.   Lushington; Mary   I.   Zgurzynski

doi:10.2174/1386207325666220422135755

[1] 
Lushington, G.H. Preface. Comb. Chem. High Throughput Screen.,  2021, 25(1), 1-2.
[2] 
Christensen, M.; Bagger, J.I.; Vilsbøll, T.; Knop, F.K. The alpha-cell as target for type 2 diabetestherapy. Rev. Diabet. Stud.,  2011, 8(3), 369-381.
[3] 
Makin, S. Cracking the genetic code of autoimmune disease. Nature,  2021, 595(7867), S57-S59.
[4] 
Conway, M.; Hu, M.; Chapman, W.W. Recent advances in using natural language processing to address public health research questions using social media and consumergenerated data. Yearb. Med. Inform.,  2019, 28(1), 208-217.
[http://dx.doi.org/10.1055/s-0039-1677918] [PMID:  31419834] 
[5] 
Tsao, S-F.; Chen, H.; Tisseverasinghe, T.; Yang, Y.; Li, L.; Butt, Z.A. What social media told us in the time of COVID-19: A scoping re-view. Lancet Digit. Health,  2021, 3(3), e175-e194.
[PMID:  33518503] 
[6] 
Maxmen, A. Massive Google-funded COVID database will track variants and immunity.  Nature, 2021, d41586-021-00490–5., 
[7] 
Proal, A.D.; VanElzakker, M.B. Long covid or post-acute sequelae of covid-19 (Pasc): An overview of biological factors that may con-tribute to persistent symptoms. Front. Microbiol.,  2021, 12698169
[PMID:  34248921] 
[8] 
Wang, J. Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. J. Chem. Inf. Model.,  2020, 60(6), 3277-3286.
[http://dx.doi.org/10.1021/acs.jcim.0c00179] [PMID:  32315171] 
[9] 
von Economo, C. Encephalitis Lethargica - Its Sequelae and Treatment; Oxford University Press: London, 1931. 
[10] 
Zdrazil, B.; Richter, L.; Brown, N.; Guha, R. Moving targets in drug discovery. Sci. Rep.,  2020, 10(1), 20213.
[PMID:  33214619] 
[11] 
Brunekreef, T.E.; Otten, H.G.; van den Bosch, S.C.; Hoefer, I.E.; van Laar, J.M.; Limper, M.; Haitjema, S. Text mining ofelectronic health records can accurately identify and characterize patients with systemic lupus erythematosus. ACR Open Rheumatol.,  2021, 3(2), 65-71.
[PMID:  33434395] 

Rights & Permissions Print Cite

Article Metrics

26

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1386207325666220422135755	Print ISSN 1386-2073
Publisher Name Bentham Science Publisher	Online ISSN 1875-5402

Combinatorial Chemistry & High Throughput Screening

Can the Written Word Fuel Pharmaceutical Innovation? Part 1. An Emerging Vista from von Economo to COVID-19

Related Journals

Related Articles